Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Transfusion ; 55 Suppl 2: S13-22, 2015 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-26174892

RESUMO

BACKGROUND: Increased reporting of intravenous immunoglobulin (IVIG)-related hemolytic reactions (HRs) triggered an investigation by the German and Swiss health authorities to identify potential risk factors. STUDY DESIGN AND METHODS: From the EudraVigilance database HRs reported between 2008 and 2013 were retrieved for seven IVIG preparations. HRs were classified as mild to moderate (hemoglobin [Hb] decline < 2 g/dL)] or severe (Hb decline > 2 g/dL) and separately analyzed for IVIG doses of less than 2 g/kg body weight and 2 g/kg body weight or more. It was assessed whether HR reporting rates correlate with the isoagglutinin content of the different preparations. RESULTS: Of 569 HR cases retrieved, 103 cases were excluded due to insufficient data, leaving 466 for analysis. Ninety-three cases were classified as mild to moderate and 373 as severe. Approximately 80% of the severe HRs concerned patients with blood group A and only three patients with blood group O. Testing of isoagglutinin titers revealed substantial differences between the seven preparations. IVIG products with high anti-A/anti-B titers (≥32) had elevated HR reporting rates, particularly when cumulative doses at least 2 g/kg were administered. CONCLUSION: The isoagglutinin content of IVIGs correlates with the risk for HRs. Exclusion of high-titer donations and manufacturing steps that deplete isoagglutinins should be considered for risk mitigation. In patients with blood groups A or AB receiving doses of at least 2 g/kg, the use of IVIG batches with low isoagglutinin titers should be considered to prevent HRs.


Assuntos
Sistema ABO de Grupos Sanguíneos/sangue , Bases de Dados Factuais , Hemaglutininas/efeitos adversos , Imunoglobulinas Intravenosas/efeitos adversos , Isoanticorpos/efeitos adversos , Feminino , Hemaglutininas/administração & dosagem , Hemaglutininas/química , Hemoglobinas/metabolismo , Humanos , Imunoglobulinas Intravenosas/administração & dosagem , Imunoglobulinas Intravenosas/química , Isoanticorpos/administração & dosagem , Isoanticorpos/química , Masculino , Fatores de Risco
2.
Omega (Westport) ; 59(1): 69-89, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19634507

RESUMO

The continued bonds between bereaved individuals and the deceased are central to the process of mourning. One challenging form of continuing bond is that in which the mourner senses the actual presence of the deceased--i.e., seeing one's deceased husband at the kitchen counter. Some see this experience as a sign of pathology while others see it as a normal, healthy aspect of grief and mourning. Twenty-one social workers shared their experiences in addressing this issue with clients. Despite conceptualizing this experience in a variety of ways, they all grounded their interactions with clients around this issue on the fundamental social work value of respecting the client's dignity and experience. Their experiences and insights may be useful to other practitioners.


Assuntos
Atitude Frente a Morte , Luto , Relações Interpessoais , Apego ao Objeto , Serviço Social/métodos , Adaptação Psicológica , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Tanatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA